Neutrophils traffic in cancer nanodrugs

journal article·2017-07

Satoru Osuka, Erwin G. Van Meir

Nature Nanotechnology· Volume 12· Issue 7

Bibliographic record

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

OpenAlex topics: Neutrophil, Myeloperoxidase and Oxidative Mechanisms · Nanoplatforms for cancer theranostics · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Show source-provided references

1. Van Meir, E. G. et al. CA Cancer J. Clin. 60, 166–193 (2010).10.3322/caac.20069 ↗

2. Van Meir, E. G., Sawamura, Y, Diserens, A. C., Hamou, M. F. & de Tribolet, N. Cancer Res. 50, 6683–6688 (1990).

3. Desbaillets, I., Diserens, A.-C., de Tribolet, N., Hamou, M.-F. & Van Meir, E. G. J. Exp. Med. 186, 1201–1212 (1997).10.1084/jem.186.8.1201 ↗

4. Osuka, S. & Van Meir, E. G. J. Clin. Invest. 127, 415–426 (2017).10.1172/JCI89587 ↗

5. Xue, J. et al. Nat. Nanotech. 12, 692–700 (2017).10.1038/nnano.2017.54 ↗

6. Binello, E. & Germano, I. M. Neuro. Oncol. 14, 256–265 (2012).10.1093/neuonc/nor204 ↗

7. Aboody, K. S. et al. Sci. Transl. Med. 5, 184ra59 (2013).10.1126/scitranslmed.3005365 ↗

8. Kolaczkowska, E. & Kubes, P. Nat. Rev. Immunol. 13, 159–175 (2013).10.1038/nri3399 ↗

9. Fossati, G. et al. Acta Neuropathol. 98, 349–354 (1999).10.1007/s004010051093 ↗

10. Allen, M., Bjerke, M., Edlund, H., Nelander, S. & Westermark, B. Sci. Transl. Med. 8, 354re3 (2016).10.1126/scitranslmed.aaf6853 ↗